Coherus Oncology, Inc.
Clinical trials sponsored by Coherus Oncology, Inc., explained in plain language.
-
New antibody drug shows promise in early cancer trial
Disease control CompletedThis early-stage study tested a new drug called CHS-388 in 145 people with advanced solid tumors (like kidney, liver, or lung cancer) that had stopped responding to standard treatments. The drug works by blocking a protein called IL-27 to help the immune system fight cancer. The …
Phase: PHASE1 • Sponsor: Coherus Oncology, Inc. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New hope for liver cancer? drug combo trial shows promise
Disease control CompletedThis study tested whether adding a new drug called SRF388 to standard treatment (atezolizumab and bevacizumab) helps people with advanced liver cancer live longer without their cancer growing. Thirty adults who had not received prior treatment for their advanced liver cancer took…
Phase: PHASE2 • Sponsor: Coherus Oncology, Inc. • Aim: Disease control
Last updated May 13, 2026 15:58 UTC